Annual Working Capital
$7.67 M
NaN%
December 1, 2023
Summary
- As of February 26, 2025, CVKD annual working capital is $7.67 million
- During the last 3 years, CVKD annual working capital has risen by +$8.27 million (+1363.03%).
- CVKD annual working capital is now at all-time high.
Performance
CVKD Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$3.41 M
-$573.00 K-14.40%
September 1, 2024
Summary
- As of February 26, 2025, CVKD quarterly working capital is $3.41 million, with the most recent change of -$573.00 thousand (-14.40%) on September 1, 2024.
- Over the past year, CVKD quarterly working capital has stayed the same.
- CVKD quarterly working capital is now -60.92% below its all-time high of $8.71 million, reached on September 1, 2023.
Performance
CVKD Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CVKD Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1363.0% | 0.0% |
| 3 y3 years | +1363.0% | 0.0% |
| 5 y5 years | +1363.0% | 0.0% |
CVKD Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1363.0% | -60.9% | +661.1% |
| 5 y | 5-year | at high | +1363.0% | -60.9% | +661.1% |
| alltime | all time | at high | +1363.0% | -60.9% | +661.1% |
Cadrenal Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.41 M(-14.4%) |
| Jun 2024 | - | $3.98 M(-35.5%) |
| Mar 2024 | - | $6.17 M(-19.5%) |
| Dec 2023 | $7.67 M | $7.67 M(-12.0%) |
| Sep 2023 | - | $8.71 M(+177.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $3.14 M(-22.1%) |
| Mar 2023 | - | $4.04 M(-765.3%) |
| Dec 2022 | -$606.90 K | -$606.90 K(+363.3%) |
| Sep 2022 | - | -$131.00 K(+33.0%) |
| Jun 2022 | - | -$98.50 K |
FAQ
- What is Cadrenal Therapeutics annual working capital?
- What is the all time high annual working capital for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics annual working capital year-on-year change?
- What is Cadrenal Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics quarterly working capital year-on-year change?
What is Cadrenal Therapeutics annual working capital?
The current annual working capital of CVKD is $7.67 M
What is the all time high annual working capital for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high annual working capital is $7.67 M
What is Cadrenal Therapeutics annual working capital year-on-year change?
Over the past year, CVKD annual working capital has changed by +$8.27 M (+1363.03%)
What is Cadrenal Therapeutics quarterly working capital?
The current quarterly working capital of CVKD is $3.41 M
What is the all time high quarterly working capital for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high quarterly working capital is $8.71 M
What is Cadrenal Therapeutics quarterly working capital year-on-year change?
Over the past year, CVKD quarterly working capital has changed by $0.00 (0.00%)